Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Citizens BancShares Inc (FCNCA) vs Zoetis Inc (ZTS) Price & Performance

First Citizens BancShares IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

First Citizens BancShares Inc vs Zoetis Inc — how do they compare? First Citizens BancShares Inc trades at $2,258.55 (market cap $25.04B), while Zoetis Inc trades at $72.36 (market cap $31.14B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.

FCNCAZTS
Market Cap
$25.04B$31.14B
Sector
Sector/ThematicHealth
52-Week High
$2.25K$156.76
52-Week Low
$1.64K$71.91
Dividend Yield
0.37%2.81%
Enterprise Value
$38.70B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Citizens BancShares Inc

First Citizens BancShares (FCNCA) trades at $2,258.55, up 1.13% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a P/E of 12.08 and net income margin of 25.23%, supported by positive cash flow trends and strategic expansions in commercial banking services. Recent news highlights institutional investments and new leadership appointments, reinforcing growth initiatives.

Outlook remains favorable due to consistent earnings outperformance and expanding business segments, though risks include elevated uninsured deposits and net interest margin pressure. Analyst consensus is mixed with a hold-heavy rating, but the stock offers value with upside to the $2,310 price target. Investors should weigh solid profitability against sector-specific headwinds.

Zoetis Inc

Zoetis (ZTS) trades at $74.86, up 3.03% today but facing bearish technical signals with 16 sell indicators. The company reported mixed Q2 2026 results, beating EPS estimates but missing revenue expectations, while cutting full-year guidance due to softer pet healthcare demand. Strong fundamentals include a 27.69% net margin and 64.91% ROE, though valuation metrics show a P/E of 12.29 and P/S of 3.41.

The stock presents a value opportunity with analyst consensus target of $94.90 (27% upside), but faces near-term headwinds from competitive pressures and class action lawsuits. Investors should weigh strong profitability against slowing growth in companion animal segments and technical bearishness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.

Read more on FCNCA

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS